SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-325946
Filing Date
2021-11-10
Accepted
2021-11-10 16:03:32
Documents
48
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d219235d10q.htm   iXBRL 10-Q 1291839
2 EX-10.1 d219235dex101.htm EX-10.1 342131
3 EX-31.1 d219235dex311.htm EX-31.1 10645
4 EX-31.2 d219235dex312.htm EX-31.2 10442
5 EX-32.1 d219235dex321.htm EX-32.1 5178
11 GRAPHIC g219235g1103113103609.jpg GRAPHIC 3779
  Complete submission text file 0001193125-21-325946.txt   5169902

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cbay-20210930.xsd EX-101.SCH 34649
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20210930_cal.xml EX-101.CAL 27213
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20210930_def.xml EX-101.DEF 157454
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20210930_lab.xml EX-101.LAB 268153
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20210930_pre.xml EX-101.PRE 208163
12 EXTRACTED XBRL INSTANCE DOCUMENT d219235d10q_htm.xml XML 747908
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 211396464
SIC: 2834 Pharmaceutical Preparations